Hot Products

Miroestrol
Catalog No: CFN91612

Miroestrol is a highly active phytoestrogen. Miroestrol can produce mammogenic effect. Miroestrol exhibits bone loss prevention and neuroprotective in ovariectomized mice. Miroestrol also can reduce cancer risk.

Mitoxantrone 2HCl
Catalog No: CFN60368

Mitraphylline
Catalog No: CFN91048

Mitraphylline has antiproliferative effects on human glioma and neuroblastoma cell lines. It also has anti-inflammatory activity, it inhibits lipopolysaccharide-mediated activation of primary human neutrophils.

Mogrol
Catalog No: CFN90936

Mogrol has exhibited anti-cancer activities, it suppressed leukemia cell growth via inhibition of the ERK1/2 and STAT3 pathways, in particular, through the suppression of p-ERK1/2 and p-STAT3. Mogrol significantly improved LPS-induced memory impairment in mice. It also suppressed adipogenesis by reducing CREB activation in the initial stage of cell differentiation and by activating AMPK signaling in both the early and late stages of this process.

Mogroside II-A2
Catalog No: CFN92203

Mogroside II-A2 is a natural product from Siraitia grosvenorii Swingle.

Mogroside IIe
Catalog No: CFN92191

Mogroside IIe is a bitter triterpenoid saponin which is the main component of unripe Luo Han Guo fruit and a precursor of the commercially available sweetener mogroside V.

Mogroside III
Catalog No: CFN92190

The human intestinal bacteria shows potent ability to transform Mogroside III to release secondary glycoside mogroside II(A1) and aglycone mogrol.

Mogroside III-A1
Catalog No: CFN92193

Mogroside III-A1 is a natural product from Siraitia grosvenorii Swingle.

Mogroside III-A2
Catalog No: CFN92946

Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.

Mogroside IV
Catalog No: CFN90389

Mogrosides IV is a sweet minor cucurbitane glycoside, it exhibits maltase inhibitory effect. Mogroside IV, Mogroside V and combinations thereof act as a Toll -Like Receptor -4 agonist and immune stimulant that can be utilized for both therapeutic vaccine design in cancer and for other pathogenic agents; therapy with Mogroside IV, Mogroside V and combinations thereof are also presented to created immune clearance of a viral infection.